Evomed recently participated in the Accuray Distributor Meeting held in Casablanca , representing Greece within Accuray’s international network of partners and distributors. The meeting brought together professionals from across the global Accuray community who are actively involved in the field of radiation therapy and oncology technology . It provided an excellent opportunity to exchange knowledge, discuss market developments, and explore the future direction of advanced cancer treatment technologies. The future of modern radiation therapy During the meeting, Accuray presented updates and developments related to its innovative radiation therapy solutions, focusing on technologies that enhance treatment precision, patient safety, and clinical efficiency . Key discussions highlighted advancements in: Image-guided radiation therapy (IGRT) Adaptive radiation therapy Stereotactic body radiation therapy (SBRT) Technologies designed to improve the accuracy of tumor targeting while protecting healthy tissue These innovations continue to shape the future of radiation oncology by enabling more personalized and effective treatment approaches. Global collaboration in radiation oncology Beyond the scientific and technological presentations, the meeting also created valuable opportunities to connect with leading professionals from the international Accuray network. Radiation oncologists, medical physicists, and industry experts shared insights and experiences from clinical practice and technology implementation around the world. Such international meetings strengthen collaboration and contribute to the continued advancement of modern radiation therapy technologies  in clinical environments. Evomed’s commitment to radiation therapy innovation in Greece As a partner of Accuray in Greece, Evomed remains committed to supporting the adoption of advanced radiation therapy technologies  and providing expertise to the local medical community. Participation in international meetings like this ensures continuous access to the latest technological developments and strengthens collaborations that ultimately benefit cancer treatment and patient care. Casablanca provided an inspiring setting for meaningful discussions, new partnerships, and a shared vision for the future of radiation therapy.

evomed  had the pleasure of participating in the VisionRT Annual Distributor Meeting , representing the company as the exclusive distributor  of VisionRT’s innovative Surface Guided Radiation Therapy (SGRT) solutions in Greece and Cyprus . The meeting brought together VisionRT partners from around the world and provided an excellent opportunity to exchange insights on strategy, innovation, and the future direction of SGRT. Discussions focused on upcoming developments, clinical impact, and the continued evolution of technologies that enhance precision and patient safety in radiotherapy. Our participation reinforces evomed’s commitment to continuously bringing state-of-the-art medical technologies to the Greek and Cypriot markets and to supporting clinical teams with solutions that make a meaningful difference in daily practice. We would like to thank VisionRT  for the excellent organization and the productive discussions, and we look forward to continuing our close collaboration in advancing precision, patient-centered radiotherapy.

With great pleasure, we announce that Evomed  is now official representative of Accuray  in Greece — a company that has reshaped the field of radiotherapy for decades through technologies such as CyberKnife®  and Radixact® . This collaboration is more than a new commercial step; it is an opening toward the future of targeted, truly personalized treatment.Technology that breathes with the patient. Precision that honors time, life, and hope. Our goal is to bring to the country’s oncology units solutions that stand out for their quality, effectiveness, and genuine clinical impact. With Accuray by our side, we strengthen Evomed’s mission: to support healthcare professionals with technology that makes a real difference — not in words, but in daily practice. What this partnership means Full availability and support of CyberKnife® , Radixact® , and the TomoTherapy®  platform. Ongoing educational and clinical engagement through presentations, workshops, and technical sessions. Long-term commitment to reliable service, technical support, and strategic development of radiotherapy centers. At Evomed, we believe in the power of innovation when it serves the human being.With Accuray, this commitment becomes even clearer — a brighter line guiding the path forward.

In Dubai, in an impressive ceremony organized by VisionRT, the company that invented SGRT superficial guided radiotherapy, the Greek medical equipment company EVOMED was awarded the title of “Distributor of the Year” for the year 2022. This particular distinction is the most honorable distinction that a representation company can receive and this makes us particularly proud, as we had to “compete” with great participants – representatives from all over Europe, the Middle East, Asia and India. The award was received by the Founder and General Manager of the company, Panagiotis Xydias. SGRT technology, invented by VisionRT in 2001, is the most modern addition to the field of cancer treatment and specifically radiotherapy. SGRT-VisionRT upgrades an existing radiotherapy system, so that it can achieve greater radiation accuracy in moving tumors due to breathing, protect the heart during irradiation of the left breast, eliminate the use of permanent tattoos and markers, and offer overall a higher quality and safer radiotherapy, comparable to the leading radiotherapy centers abroad. The development of SGRT by VisionRT is a great example that technology can and should be an aid in improving people's lives, when used correctly and with the person himself and his needs in mind. Our goal at EVOMED is for people to live with the best possible quality and this is also our most important corporate value! A value that motivates us to search for innovative technologies in the global scientific market that serve human needs and to introduce them exclusively to the Greek Medical Community.

Technology meets precision, and innovation stands beside life itself. The Interbalkan Medical Center of Thessaloniki  takes a bold step into the future of radiotherapy  with the first combined installation in Greece  of three cutting-edge systems from VisionRT : AlignRT Horizon , AlignRT InBore , and SimRT . Installed and supported by Evomed , this powerful combination brings the center’s technological capabilities in line with top-tier European oncology institutions, offering treatments with unmatched accuracy, safety, and a truly patient-centered approach . What is AlignRT Horizon? AlignRT Horizon  is VisionRT’s most advanced Surface Guided Radiation Therapy (SGRT)  system to date. With lightning-fast capture speeds, ultra-high resolution, and advanced motion filtering, it delivers submillimeter accuracy  in monitoring and aligning patient position — in real time, without tattoos, additional radiation, or invasive markers. AlignRT InBore: Precision Inside Closed-Bore Linacs AlignRT InBore  enables full SGRT functionality in closed-bore linear accelerators such as the Varian Halcyon . This opens the door to heart-sparing DIBH (Deep Inspiration Breath Hold) techniques  and ultra-precise beam delivery for Halcyon users — with continuous tracking and automatic beam hold for maximum patient safety. SimRT: Accuracy from Simulation to Treatment SimRT  brings SGRT into the simulation phase , allowing clinicians to digitally capture and reference the patient’s optimal position from the very first session . This ensures reproducibility and minimizes positional corrections during treatment. The result? Smoother workflows, increased accuracy, and more consistent outcomes. Technology That Protects the Heart — and Inspires Trust With the integration of these systems, the Interbalkan Medical Center  becomes one of Europe’s most comprehensively equipped SGRT centers . Capable of delivering advanced techniques such as DIBH, SBRT, and SRS , the center now offers: High-precision radiotherapy  for complex anatomical sites Documented heart protection  during left breast irradiation Lower overall radiation dose  by minimizing the need for additional imaging Streamlined clinical workflows  with real-time beam monitoring It's worth noting: Only VisionRT’s AlignRT has been featured in peer-reviewed studies proving significant heart dose reduction in breast radiotherapy . For patients seeking evidence-based technology, this is the name to look for . Evomed: Empowering Innovation As VisionRT’s official partner in Greece, Evomed  handled the full installation, configuration, and clinical staff training. Because technology only becomes meaningful when combined with deep expertise, our mission is to ensure each system delivers maximum clinical value — from day one. Precision. Protection. Innovation. With this strategic upgrade, the Interbalkan Medical Center of Thessaloniki  becomes a national and regional benchmark in radiotherapy excellence. And this is only the beginning.

In Crete, where medical care meets human compassion, the University Hospital of Heraklion (PAGNI)  takes a significant step into the future of radiotherapy . We are proud to announce the successful installation of the AlignRT system  by VisionRT (UK)  in the hospital’s radiotherapy department — an innovation that brings advanced precision and proven safety to cancer treatment on the island. Installed and supported by Evomed , the system is now fully integrated into clinical use, with the hospital’s staff having undergone comprehensive training to maximize its clinical impact. What is AlignRT? AlignRT  is a cutting-edge Surface Guided Radiation Therapy (SGRT)  system that monitors the patient’s position in real time — without tattoos, invasive markers, or additional radiation. Using 3D surface imaging technology, AlignRT ensures that radiation is delivered only to the intended target , with sub-millimeter accuracy. It’s a system designed not just to treat, but to protect . Heart Protection in Left Breast Radiotherapy: Proven and Exclusive The installation of AlignRT at PAGNI is particularly significant for patients undergoing left breast radiotherapy . The system supports the DIBH (Deep Inspiration Breath Hold)  technique, which allows patients to hold a deep breath, naturally moving the heart away from the radiation field. Crucially, all peer-reviewed studies that have demonstrated statistically significant heart dose reduction have been conducted using VisionRT’s AlignRT . This is not just promise — it’s proven protection. Patients who are informed about their treatment options should look specifically for this technology  when heart safety is a concern. A First for Crete – A Step Forward for Oncology With the installation of AlignRT, PAGNI becomes the first and only radiotherapy center in Crete  to offer: High-precision treatments  for various anatomical regions Proven heart protection  for left breast irradiation Reduced imaging and unnecessary radiation exposure A non-invasive, patient-friendly approach  without permanent skin marks SGRT doesn’t just enhance infrastructure — it elevates the standard of care . It represents a commitment to both technological excellence and patient safety . Evomed: Empowering Innovation with Support At Evomed , we stand beside every hospital that chooses evidence-based innovation. From installation to training, we ensure that technology becomes clinical reality , and that every upgrade translates into better outcomes for patients . PAGNI is now looking ahead — with precision, safety, and compassion. Radiotherapy in Crete has entered a new era. And the journey has just begun.